… In conclusion, allogeneic hematopoietic cell transplantation offers curative therapy for patients
with myelofibrosis, generally with structural normalization of the marrow. Results with HLA-…

… , for the treatment of patients with myelofibrosis (MF). Although … Presently, allogeneic
hematopoietic cell transplantation (HCT) … compared with HCT in MF patients are analyzed. A risk-…

… Nowadays, there are comprehensive guidelines concerning allogeneic hematopoietic stem
cell transplantation for patients with myelofibrosis. However, it commonly remains difficult for …

… The aim of this review is to update the current status of allogeneic hemopoietic stem cell
transplants (HSCT) for patients with myelofibrosis (MF). We have first summarized the issue of …

… We describe the course of 25 patients with myelofibrosis (MF) due to agnogenic myeloid …
cell transplantation (SCT) at one of two Canadian centers. The median age at transplantation …

… stem cell engraftment. Nevertheless, we observed one primary graft failure in a high-risk
patient with post-thrombocythemic myelofibrosis, who received peripheral blood stem cells from …

… Dose-reduced conditioning followed by allogeneic stem cell transplantation in patients with
myelofibrosis. Results from a multicenter prospective trial of the Chronic Leukemia Working …

… Patients with primary myelofibrosis who underwent a first allogeneic BM or peripheral
blood stem cell transplant (PBSCT) using an HLA matched sibling donor, unrelated donor (URD), …

… outcome of patients with myelofibrosis who underwent allogeneic stem cell transplantation,
… We conclude that the outcome of myelofibrosis patients who underwent allogeneic stem cell …

… Kaplan-Meier estimates of the probability of survival in 55 patients who received an allogeneic
stem cell transplant for AMM. The 5-year probability of overall survival was 47% for the …